Regional Dynamics in API Production
The global Montelukast API (Active Pharmaceutical Ingredient) market plays a critical role in the pharmaceutical industry, serving as the essential building block for a widely prescribed medication used to manage respiratory conditions. Montelukast, a leukotriene receptor antagonist, is a cornerstone treatment for asthma and allergic rhinitis. The market for its API is dynamic and experiencing significant expansion. While different reports provide varying figures, a clear and consistent growth trajectory is evident. The market was valued at approximately USD 1.01 billion to USD 1.6 billion in 2024 and is projected to reach an estimated value of USD 2.3 billion to USD 2.7 billion by 2034. This growth is underpinned by a robust Compound Annual Growth Rate (CAGR) ranging from 6.6% to over 10% during the forecast period. This strong performance is driven by the increasing global prevalence of chronic respiratory disorders, a surge in generic drug demand, and…